Efficacy Study of Femoral Nerve Block in Children With a Femur Fracture
NCT ID: NCT01294098
Last Updated: 2018-03-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
2 participants
INTERVENTIONAL
2011-02-28
2014-10-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Femoral Nerve Block for Femur Fracture Repair in Pediatrics
NCT01759407
Comparison of Femoral Nerve Block Versus Fascia Iliaca Compartment Block for Pain Control in Traumatic Femur Fracture Repair in Pediatric Population
NCT05882201
Dorsal Nerve Block and Caudal Block in Hypospedius Repair in Children
NCT06500286
Retrospective Femoral Nerve Block Study
NCT01293136
The Effect of Femoral Nerve Block on Opioid Requirements After Surgery for a Femur Fracture in Children
NCT00175591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCA only
this group will only get a pain control anesthesia pump to use for post-operative pain
No interventions assigned to this group
PCA and femoral nerve block
this group will be receiving a femoral nerve block during surgery and have a PCA post-operatively
Marcaine
0.75 cc/kg of 1/4% Marcaine
PCA + hematoma block
patient will receive hematoma block during surgery
Marcaine
0.75 cc/kg of 1/4% Marcaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Marcaine
0.75 cc/kg of 1/4% Marcaine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Weight of 30-100 Kg
* Child must be older than 6 years old
Exclusion Criteria
* A child that has a pain abnormality
* Any child with an allergy to local anesthetic
* Any child with a neurological injury
* Any child with the inability to report pain
* Any child that is unable to use a PCA post-operatively
7 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J. Eric Gordon, MD
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Louis Childrens Hospital
St Louis, Missouri, United States
Washington University
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-0331
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.